本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Royalty Pharma plc

47.90
-0.4000-0.83%
盤後47.900.00000.00%16:10 EDT
成交量:236.76萬
成交額:1.14億
市值:279.34億
市盈率:26.89
高:48.36
開:48.30
低:47.73
收:48.30
52周最高:49.06
52周最低:30.31
股本:5.83億
流通股本:3.80億
量比:0.91
換手率:0.62%
股息:0.90
股息率:1.88%
每股收益(TTM):1.78
每股收益(LYR):1.78
淨資產收益率:13.20%
總資產收益率:5.15%
市淨率:4.31
市盈率(LYR):26.89

資料載入中...

2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities